99 related articles for article (PubMed ID: 8781311)
1. Hepatitis B virus mutations in the pre-S genome before and after liver transplantation.
Trautwein C; Schrem H; Tillmann HL; Kubicka S; Walker D; Böker KH; Maschek HJ; Pichlmayr R; Manns MP
Hepatology; 1996 Sep; 24(3):482-8. PubMed ID: 8781311
[TBL] [Abstract][Full Text] [Related]
2. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
Torre F; Wong PY; Macartney M; Williams R; Naoumov NV
J Med Virol; 1999 Sep; 59(1):5-13. PubMed ID: 10440801
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis B virus gene mutations in the sera of three patients with coexisting hepatitis B surface antigen and anti-surface antibody].
Yukimasa N; Ohkushi H; Fukasawa K; Fukuchi K; Takagi Y; Gomi K
Rinsho Byori; 2000 Feb; 48(2):184-8. PubMed ID: 10804824
[TBL] [Abstract][Full Text] [Related]
4. Liver graft infection by HBV S-gene mutants in transplant patients receiving long-term HBIg prophylaxis.
Santantonio T; Gunther S; Sterneck M; Rendina M; Messner M; Launois B; Francavilla A; Pastore G; Will H
Hepatogastroenterology; 1999; 46(27):1848-54. PubMed ID: 10430358
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.
Ghany MG; Ayola B; Villamil FG; Gish RG; Rojter S; Vierling JM; Lok AS
Hepatology; 1998 Jan; 27(1):213-22. PubMed ID: 9425940
[TBL] [Abstract][Full Text] [Related]
6. Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation.
Hussain M; Soldevila-Pico C; Emre S; Luketic V; Lok AS;
Liver Transpl; 2007 Aug; 13(8):1137-44. PubMed ID: 17663390
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation.
McMillan JS; Bowden DS; Angus PW; McCaughan GW; Locarnini SA
Hepatology; 1996 Dec; 24(6):1371-8. PubMed ID: 8938164
[TBL] [Abstract][Full Text] [Related]
8. Pretransplantation pre-S2 and S protein heterogeneity predisposes to hepatitis B virus recurrence after liver transplantation.
Grottola A; Buttafoco P; Del Buono MG; Cremonini C; Colantoni A; Gelmini R; Morelli C; Masetti M; Jovine E; Fruet F; Pinna A; Manenti F; Villa E
Liver Transpl; 2002 May; 8(5):443-8. PubMed ID: 12004344
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis.
Carman WF; Trautwein C; van Deursen FJ; Colman K; Dornan E; McIntyre G; Waters J; Kliem V; Müller R; Thomas HC; Manns MP
Hepatology; 1996 Sep; 24(3):489-93. PubMed ID: 8781312
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the changes of HBV serum markers and HBV DNA and the effects of perioperative factors after liver transplantation].
Tang YM; Chen GH; He XS; Zhu XF; Chen MH
Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):164-7. PubMed ID: 15760545
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation.
Protzer-Knolle U; Naumann U; Bartenschlager R; Berg T; Hopf U; Meyer zum Büschenfelde KH; Neuhaus P; Gerken G
Hepatology; 1998 Jan; 27(1):254-63. PubMed ID: 9425945
[TBL] [Abstract][Full Text] [Related]
12. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection.
Bozdayi G; Türkyilmaz AR; Idilman R; Karatayli E; Rota S; Yurdaydin C; Bozdayi AM
J Med Virol; 2005 Aug; 76(4):476-81. PubMed ID: 15977237
[TBL] [Abstract][Full Text] [Related]
13. Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients.
Preikschat P; Günther S; Reinhold S; Will H; Budde K; Neumayer HH; Krüger DH; Meisel H
Hepatology; 2002 Feb; 35(2):466-77. PubMed ID: 11826424
[TBL] [Abstract][Full Text] [Related]
14. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR
Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation.
Sterneck M; Günther S; Santantonio T; Fischer L; Broelsch CE; Greten H; Will H
Hepatology; 1996 Aug; 24(2):300-6. PubMed ID: 8690396
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
17. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
18. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.
Tacke F; Liedtke C; Bocklage S; Manns MP; Trautwein C
Gut; 2005 Sep; 54(9):1309-17. PubMed ID: 15871998
[TBL] [Abstract][Full Text] [Related]
19. Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E.
Fujiwara K; Tanaka Y; Paulon E; Orito E; Sugiyama M; Ito K; Ueda R; Mizokami M; Naoumov NV
J Virol; 2005 Nov; 79(22):14404-10. PubMed ID: 16254374
[TBL] [Abstract][Full Text] [Related]
20. [Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].
Zheng S; Wu J; Wang W; Huang D; Liang T; Lu A
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):445-8. PubMed ID: 12133511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
